Aurobindo Pharma

Company Overview

Aurobindo Pharma Ltd. is a leading global generic pharmaceutical company and is currently positioned as India’s second-largest pharmaceutical company in terms of revenue. The company develops, manufactures, and commercializes a diverse portfolio of generics, specialty drugs and injectables, APIs, and complex offerings, including biosimilars, vaccines, peptides, and metered dose inhalers globally. Aurobindo Pharma sells its products in over 150 countries.

The company operates in two major business segments: Formulations and API. The formulations business develops and manufactures a diverse range of pharmaceutical products across key therapeutics areas, including central nervous system, anti-diabetics, cardiovascular, oncology, antibiotics, dermatology, and antiretroviral. API business segment manufacturers API catering to both captive requirements and external customers.

Financial Highlights (FY 2022)

Company's Business Segments

• Sale of products : This segment Manufacture, Market a wide range of Generic Pharmaceuticals, Active Pharmaceutical Ingredients (APIs) across various therapeutic areas, including Cardiovascular, Central Nervous System, Anti-retroviral, Anti-diabetics, Gastroenterology, Anti-infective. Their product portfolio includes Tablets, Capsules, Injectables, and more.
• Sale of services : This segment provide Contract Manufacturing services to other pharmaceutical companies. This involves utilizing their manufacturing facilities and expertise to produce pharmaceutical products on behalf of other companies under contract.
• Other operating revenue : This segment includes revenue from Scrap Sales, Government Incentive Schemes.